Evidence map›Paper›PMID 34374749›Full record

ArticleBlood advances2021

Methodology for adaptation of the ASH Guidelines for Management of Venous Thromboembolism for the Latin American context.

Ignacio Neumann, Ariel Izcovich, Kendall E Alexander, Jenny Castano, Robert Plovnick, Robert Kunkle, Yuan Zhang, Ricardo Aguilar, Guillermo León Basantes, Patricia Casais and 9 more

Abstract read
In one paragraph

Article in Blood advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. An international guideline training and certification programme.Bulletin of the World Health Organization · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Ignacio NeumannDepartment of Internal Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Ariel IzcovichHospital Alemán, Buenos Aires, Argentina.ORCID 0000-0001-9053-4396
Kendall E AlexanderAmerican Society of Hematology, Washington, DC.
Jenny CastanoAmerican Society of Hematology, Washington, DC.
Robert PlovnickAmerican Society of Hematology, Washington, DC.
Robert KunkleAmerican Society of Hematology, Washington, DC.
Yuan ZhangDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.ORCID 0000-0002-4174-0641
Ricardo AguilarServicio de Hematología, Complejo Hospitalario Dr. Arnulfo Arias Madrid, Panama City, Panama.
Guillermo León BasantesClínica Universitaria Colombia, Bogotá, Colombia.
Patricia CasaisEpidemiología Clínica y Evidencia, Instituto de Investigaciones en Salud Pública, Universidad de Buenos Aires, Buenos Aires, Argentina.ORCID 0000-0002-0121-150X
Cecilia C ColorioFundación Favaloro, Buenos Aires, Argentina.
María Cecilia Guillermo EspositoHospital de Clínicas Dr. Manuel Quintela, Montevideo, Uruguay.ORCID 0000-0003-2748-8889
Pedro P García LázaroFaculty of Medicine, Universidad Privada Antenor Orrego, Trujillo, Peru.ORCID 0000-0003-4521-4048
Jaime PereiraDepartment of Hematology and Oncology, Pontificia Universidad Católica de Chile, Santiago, Chile.ORCID 0000-0003-0481-328X
Luis A Meillon-GarcíaThe ABC Medical Center, Mexico City, Mexico.
Suely Meireles RezendeDepartment of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Juan Carlos SerranoUnidad Hematológica Especializada IPS, Cucuta, Colombia; and.
Mario L Tejerina ValleCaja Petrolera de Salud, La Paz, Bolivia.
Holger SchünemannDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.ORCID 0000-0003-3211-8479

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFrom 2017 to 2020, the American Society of Hematology (ASH) collaborated with 12 hematology societies in Latin America to adapt the ASH guidelines on venous thromboembolism (VTE).

objectiveTo describe the methods used to adapt the ASH guidelines on venous thromboembolism.

methodsEach society nominated 1 individual to serve on the guideline panel. The work of the panel was facilitated by the 2 methodologists. The methods team selected 4 of the original VTE guidelines for a first round. To select the most relevant questions, a 2-step prioritization process was conducted through an on-line survey and then through in-person discussion. During an in-person meeting in Rio de Janeiro, Brazil, from 23 April through 26 April 2018, the panel developed recommendations using the ADOLOPMENT approach. Evidence about health effects from the original guidelines was reused, but important data about resource use, accessibility, feasibility, and impact in health equity were added.

resultsIn the guideline accompanying this paper, Latin American panelists selected 17 questions from an original pool of 49. Of the 17 questions addressed, substantial changes were introduced for 5 recommendations, and remarks were added or modified for 12 recommendations.

conclusionsBy using the evidence from an international guideline, a significant amount of work and time were saved; by adding regional evidence, the final recommendations were tailored to the Latin American context. This experience offers an alternative to develop guidelines relevant to local contexts through a global collaboration.

Indexed as

HematologyVenous ThromboembolismBrazilEvidence-Based MedicineHumansLatin America

Identifiers

PMID34374749
PMCPMC8361463

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.